Today: 7 February 2026
Subscribe
Browse Category

Earnings Reports News 28 January 2026

GSK share price slips in London as Arexvy EU expansion sinks in; earnings next week in focus

GSK share price slips in London as Arexvy EU expansion sinks in; earnings next week in focus

GSK shares dropped 1.8% to 1,828.5 pence by mid-morning Wednesday in London, reversing gains from earlier in the week. The decline followed news that the European Commission expanded approval of GSK’s RSV vaccine Arexvy to all adults 18 and older. Pfizer also secured similar approval for its RSV shot. Investors await guidance from European health agencies and GSK’s earnings report on February 4.
28 January 2026
···
Unilever share price slips in early London trade as investors line up February results

Unilever share price slips in early London trade as investors line up February results

Unilever shares slipped 0.7% to 4,831.5 pence in early London trading, underperforming the FTSE 100’s 0.1% drop. Investors await Unilever’s full-year results on Feb. 12, focusing on volume growth and margins after the company spun off its Magnum unit and consolidated shares. European stocks paused after a two-day rally, with attention shifting to the U.S. Fed decision later today.
28 January 2026
··
Yangzijiang Shipbuilding stock edges up to S$3.33 as Singapore STI dips — traders eye Fed, March earnings

Yangzijiang Shipbuilding stock edges up to S$3.33 as Singapore STI dips — traders eye Fed, March earnings

Yangzijiang Shipbuilding shares rose 0.3% to S$3.33 in afternoon trading Wednesday, rebounding after a late-January dip but still 11% below their Jan. 14 high. Short selling made up 43% of Tuesday’s 20.3 million shares traded. Singapore’s Straits Times Index slipped 0.47% after a 1.28% gain Tuesday. Yangzijiang’s next earnings release is scheduled for March 4.
28 January 2026
··
Woodside Energy share price jumps after Q4 report, but 2026 output dip keeps traders cautious

Woodside Energy share price jumps after Q4 report, but 2026 output dip keeps traders cautious

Woodside Energy shares rose 2.7% to A$24.98 after its fourth-quarter update, despite forecasting lower 2026 output due to scheduled downtime at Pluto LNG. December-quarter revenue fell to $3.035 billion from $3.484 billion a year earlier. Scarborough project is 94% complete, with first LNG cargo expected in late 2026. Investors await the annual report briefing on Feb. 24.
28 January 2026
···
Why Gilead stock hit a fresh 52-week high as Medicare targets Biktarvy and earnings loom

Why Gilead stock hit a fresh 52-week high as Medicare targets Biktarvy and earnings loom

Gilead Sciences shares rose 2.3% to $140.97 Tuesday, hitting a 52-week high after Medicare named its HIV drug Biktarvy for price negotiations starting in 2028. Trading volume topped 10.5 million shares. CEO Daniel O’Day sold 115,640 shares last week under a pre-set plan. Gilead will report fourth-quarter and full-year results after markets close on Feb. 10.
28 January 2026
···
HCA stock jumps after earnings and a $10B buyback — what to watch before Wednesday’s open

HCA stock jumps after earnings and a $10B buyback — what to watch before Wednesday’s open

HCA Healthcare shares surged 7.1% to $505.84 after the company raised its 2026 profit outlook and approved a new $10 billion share buyback. Fourth-quarter revenue rose 6.7% to $19.51 billion, with net income at $1.88 billion. Investors remain cautious as ACA exchange subsidies expire, potentially reducing patient volumes. The board also declared a $0.78 quarterly dividend, payable March 31.
28 January 2026
··
Starbucks stock dips as supply-chain snags and CEO jet policy land ahead of earnings

Starbucks stock dips as supply-chain snags and CEO jet policy land ahead of earnings

Starbucks shares fell 0.6% to $95.72 Tuesday ahead of its fiscal first-quarter earnings report set for Wednesday morning. CEO Brian Niccol is under scrutiny as supply-chain issues persist despite new technology and system upgrades. The company also removed the $250,000 cap on Niccol’s personal use of the corporate jet after a security review. Wall Street analysts adjusted price targets as investors focus on sales and margins.
28 January 2026
··
1 … 71 72 73 74 75 … 337

Stock Market Today

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

7 February 2026
Kenvue shares closed Friday at $18.13, up 0.33%, with about 63.5 million shares traded. The Kimberly-Clark offer values Kenvue at roughly $18.76 per share, leaving a deal spread of about 3%. Both companies’ shareholders approved the merger, which is expected to close in the second half of 2026 pending regulatory approvals. Kenvue’s dividend record date is Feb. 11, with earnings due Feb. 17.
IREN stock heads into Monday after 5% rebound as Microsoft AI financing stays in focus

IREN stock heads into Monday after 5% rebound as Microsoft AI financing stays in focus

7 February 2026
IREN shares closed up 5.1% at $41.83 Friday after reporting a $155.4 million quarterly loss and $184.7 million in revenue. The company announced $3.6 billion in GPU financing for its Microsoft contract, with $2.8 billion in cash as of Jan. 31. Bitcoin mining revenue fell, while AI cloud services rose. Traders await bitcoin’s weekend move and Monday’s market reaction.
Cadence Bank stock is stuck at $42.11 after Huntington deal — what CADE holders watch next week

Cadence Bank stock is stuck at $42.11 after Huntington deal — what CADE holders watch next week

7 February 2026
Cadence Bank shares have been delisted following Huntington Bancshares’ takeover, with each Cadence share converted into 2.475 Huntington shares. Huntington closed Friday at $19.27 and named Senthil Kumar as chief risk officer ahead of new regulatory requirements. The merger leaves Cadence as a brand under Huntington, with customer account conversions planned for mid-2026. Huntington executives will address investors at a UBS conference on Tuesday.
Go toTop